February 15, 2022 – In the conflict between the irresistible force and the immovable object, which one wins?
In this case, writes Physician Office Lab Columnist Jim Poggi, the battle is pitting the Protecting Access to Medicare Act (PAMA) against COVID-19, a formidable worldwide pandemic foe. PAMA is a 2014 law first enforced in 2018 with the goal of aligning Medicare payments for laboratory tests under the Clinical Lab Fee Schedule with rates paid by private insurance. When it was enacted, it caused widespread concern in the U.S. laboratory and healthcare communities. SARS COV-2 came out of the blue in late 2019 and rapidly became a worldwide healthcare concern as it created a pandemic.
How is the battle shaping up? What’s the current score and who is likely to prevail?
Read his latest column here